Treatment withdrawal · people with drug‐resistant focal epilepsy
Pregabalin showed no clear difference in treatment withdrawal for any reason compared with active comparators (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with drug‐resistant focal epilepsy
1 finding from 1 review
Ataxia · people with drug‐resistant focal epilepsy
1 finding from 1 review
Dizziness · people with drug‐resistant focal epilepsy
1 finding from 1 review
Adverse effect: fatigue · people with drug‐resistant focal epilepsy
1 finding from 1 review
Adverse effects: headache · people with drug‐resistant focal epilepsy
1 finding from 1 review
Nausea · people with drug‐resistant focal epilepsy
1 finding from 1 review
Somnolence · people with drug‐resistant focal epilepsy
1 finding from 1 review
Weight gain · people with drug‐resistant focal epilepsy
1 finding from 1 review
Seizure freedom · people with drug‐resistant focal epilepsy
1 finding from 1 review
Treatment withdrawal · people with drug‐resistant focal epilepsy
Pregabalin probably leads to higher treatment withdrawal for any reason compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with drug‐resistant focal epilepsy
Pregabalin probably leads to higher treatment withdrawal due to adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Ataxia · people with drug‐resistant focal epilepsy
Pregabalin may leads to higher adverse effect: ataxia compared with placebo (low certainty).
1 finding from 1 review
Dizziness · people with drug‐resistant focal epilepsy
Pregabalin may leads to higher adverse effect: dizziness compared with placebo (low certainty).
1 finding from 1 review
Adverse effect: fatigue · people with drug‐resistant focal epilepsy
Pregabalin showed no clear difference in adverse effect: fatigue compared with placebo (low certainty).
1 finding from 1 review
Spontaneous space closure · Children and adolescents after extraction of a mandibular permanent first molar (before eruption of the second molar)
One study found space closure more likely with crowding than spacing (OR 5.9; single study; not GRADE-rated).
1 finding from 1 review
Disease control · bullous pemphigoid
It is very uncertain whether prednisone plus azathioprine changes disease control (at 6 months) compared with prednisone (very low certainty).
1 finding from 1 review
Mortality (at 6 months) · bullous pemphigoid
It is very uncertain whether prednisone plus azathioprine changes mortality (at 6 months) compared with prednisone (very low certainty).
1 finding from 1 review
Quality of life ‐ not measured · bullous pemphigoid
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · bullous pemphigoid
1 finding from 1 review